Journal of Modern OncologyJournal of Modern OncologyСовременная онкология1815-14341815-1442LLC Obyedinennaya Redaktsiya26718ArticlesСтатьиResearch ArticleGerminogennye opukholi u bol'nykh SPIDomГерминогенные опухоли у больных СПИДомPivnikA VПивникА ВSereginN VСерегинН ВParkhomenkoYu GПархоменкоЮ ГTishkevichO AТишкевичО АKovriginaA MКовригинаА МGruzdevB MГруздевБ МPetrovaE VПетроваЕ ВLikunovE BЛикуновЕ БНациональный медико-хирургический центр им. Н.И.Пирогова, МоскваГородская клиническая больница №60, МоскваКлиническая инфекционная больница №2, МоскваРоссийский онкологический центр РАМН, МоскваМосковский городской центр СПИДФНКЦ ДГОИ Росздрава, Москва15062008102NO2 (2008)ТОМ 10, №2 (2008)596609042020Copyright ©; 2008, Consilium MedicumCopyright ©; 2008, ООО "Консилиум Медикум"2008Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc/4.0https://modernonco.orscience.ru/1815-1434/article/view/26718

В практике врача-гематолога, как правило, встречаются пациенты с периферической и средостенной лимфаденопатией, при исследовании которой будет верифицирован диагноз генерализованной герминогенной опухоли (ГЕО) с вовлечением гонад или внегонадной забрюшинной/медиастинальной локализацией. Герминомы центральной нервной системы (ЦНС) подлежат дифференциальному диагнозу с первичной лимфомой ЦНС. В данном сообщении мы приводим краткое описание трех таких наблюдений.

Нечушкина И.В. Опухоли гонад и пороки развития у детей. Рос. онкол. журн. 2002; 4: 52–4.Buetow S.A. Epidemiology of testicular cancer. Epidemiol Rev 1995; 17: 433–49.Bosl G.J., Motzer R.J. Testicular germ - cell cancer. N Engl J Med 1997; 337: 242–53.Кутушева Г.Ф., Урманчеева А.Ф. Опухоли и опухолевидные образования половых органов у девочек. Спб.,2001.Dmitrovsky E, Bosl G.J., Chaganti S.K. Clinical and genetic features of human germ cell cancer. Cancer Surv 1990; 9: 369–89.Mostofi F.K., Sesterhenn I.A., Sobin L.H. Histological typing of testis tumours, second edition, Springer. Lion 2004; 3: 540–633.Travis L.B., Curtis R.E., Storm H, Hall P et al. Risk of second malignant neoplasms among long - term survivors of testicular cancer. J Natl Cancer Inst 1997; 89: 1429–39.Mostofi F.K., Sesterhenn I.A., Sobin L.H. Histological typing of testis tumors, second edition. Berlin: Springer, 1998.Looijenga L.H., Oosterhuis J.W. Pathogenesis of testicular germ cell tumors. Rev Reproduct 1999; 4: 90–100.Gundy S, Baki M, Bodrogi I, Czeizel A. Persistence of chromosomal aberrations in blood lymphocytes of testicular cancer patients. Oncology 1990; 47: 410–4.Pedersen-Bjergaard J, Rowley J.D. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994; 83: 2780–6.Fossa S.D., Horwich A, Russell J.M. et al. Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol 1999; 17: 1146–54.Garnick M.B., Canellos G.P., Richie J.P. Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. JAMA 1983; 250: 1733–41.Pedersen-Bjergaard J, Daugaard G, Hansen S.W. et al. Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germcell tumours. Lancet 1991; 338: 359–63.Bosl G.J., Dmitrovsky E, Reuter V.E. et al. Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors. J Natl Cancer Inst 1989; 81: 1874–8.Nonomura N, Murosaki N, Kojima Y et al. Secondary acute monocytic leukemia occurring during the treatment of a testicular germ cell tumor. A case report and review of the literature. Urol Int 1997; 58: 239–42.Nichols C.R., Roth B.J., Heerema N et al. Hematologic neoplasia associated with primary mediastinal germcell tumors. N Engl J Med 1990; 1425–9.Fossa S.D, Langmark F, Aass N et al. Second nongerm cell malignancies after radiotherapy of testicular cancer with or without chemotherapy. Br J Cancer 1990; 61: 639–43.Krywicki R, Bowen K, Anderson L et al. Mixed - lineage acute myeloid leukemia associated with a suprasellar dysgerminoma. Am J Clin Oncol 1995; 18: 83–6.Ladanyi M, Samaniego F, Reuter V.E. et al. Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Ins 1990; 221–7.De Ment S.H., Eggleston J.C., Spivak J.L. Association between mediastinal germ cell tumors and hematological malignancies: report of two cases and review of the literature. Am J Surg Pathol 1985; 9: 23–30.Nichols C.R., Hoffman R, Einhorn L.H. et al. Hematologic malignancies associated with primary mediastinal germcell tumors. Ann Intern Med 1985; 102: 603–9.Nichols C.R., Roth B.J., Heerema N et al. Hematologic neoplasia associated with primary mediastinal germcell tumors. N Engl J Med 1990; 322: 1425–9.Ladanyi M, Samaniego F, Reuter V.E. et al. Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Inst 1990; 82: 221–7.Orazi A, Neiman R.S., Ulbright T.M. et al. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors. Cancer 1993; 71: 3873–81.Woodruff K, Wang N, May W et al. The clonal nature of mediastinal germ cell tumors and acute myelogenous leukemia. A case report and review of the literature. Cancer Genet Cytogenet 1995; 79: 25–31.Orazi A, Neiman R.S., Ulbright T.M. et al. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors. Cancer 1993; 71: 3873–81.Geurts van Kessel A, Van Drunen E, De Jong B et al. Chromosome 12q heterozygosity is retained in i(12p)-positive testicular germ cell tumor cells. Cancer Genet Cytogenet 1989; 40: 129–34.Irie J, Kawai K, Ueno Y et al. Malignant germ cell tumor of the anterior mediastinum with leukemia - like infiltration. Acta Pathol Jpn 1985; 1561–70.Goedert J.J., Cote T.R., Virgo P et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351: 1833–9.Sung M-T, MacLennan G.T., Lopez-Beltran A et al. Primary mediastinal seminoma. Am J Surg Pathol 2008; 32: 146–55.Hentrich M.U., Black N.G., Schmid P et al. Testicular germ cell tumors in patients with human immunodeficiency virus Infection. Cancer 1996; 77: 2109–17.Timmerman J.M., Northfelt D.W., Small E.J. Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy. J Clin Oncol 1995; 13: 1391–7.Тюляндин С.А. Лечение диссеминированных герминогенных опухолей у мужчин. Дис.. докт. мед. наук, 1993.Hentrich M.U., Brack N.G., Schmid P et al. Testicular germ cell tumors in patients with human immunodeficiency virus infection. Cancer 1996; 77: 109–16.Nichols C.R., Loehrer P.J., Einhorn L.H. et al. Phase III study of cisplatin, etoposide and bleomycin or etoposide, ifosfamide and cisplatin in advanced stage germ cell tumors: An intergroup trial. Proc Am Soc Clin Oncol 1995; 14: 239.Albers P, Weinknecht S, Krege S et al. Prediction of necrosis after chemotherapy of advanced germ cell tumors – results of a prospective multicenter trial of the GTCSG. J Urol 2002; 167: 172.De Santis M, Bokemeyer C, Becherer A et al. Predictive impact of 2-18fluoro-2- deoxy-D-glucose positron emission tomography (FDG PET) for residual postchemotherapy masses in patients with bulky seminoma. J Clin Oncol 2001; 19: 3740–4.Aprikian A.G., Herr H.W., Bajorin D.F. et al. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular non - seminomatous germ cell tumors. Cancer 1994; 74: 1329–34.Hartmann J.T., Candelaria M, Kuczyk M.A. et al. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non - seminomatous germ cell tumors. Eur J Cancer 1997; 33: 843–7.Fizazi K, Tjulandin S, Salvioni R et al. Viable malignant cells after primary chemotherapy for disseminated non - seminatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy results from an international study. J Clin Oncol 2001; 19: 2647–57.